Phreesia, Inc. (PHR): Valuation
TTM figures as of July 31, 2026
Phreesia, Inc. trades at 61.3 times trailing earnings and a 12.62% free-cash-flow yield. That FCF yield is higher than 98% of its own month-end history back to 2019. The Healthcare median P/E is 22.9.
Earnings yield 1.63%. ROIC 3.5%. Net cash $8.2M.
86 month-end valuation observations are on file, starting July 2019.
Sector comparison uses 2682 Healthcare names.
Frequently asked questions
Is PHR cheap versus its own history?
Phreesia, Inc. trades at 61.3 times trailing earnings and a 12.62% free-cash-flow yield. That FCF yield is higher than 98% of its own month-end history back to 2019. The Healthcare median P/E is 22.9.
What is PHR's free-cash-flow yield?
Phreesia, Inc. currently yields 12.62% of market cap as trailing free cash flow.
Where do these valuation figures come from?
Yields and quality metrics are computed from the same SEC TTM figures as the financials page, against the live market cap. Historical bands reconstruct month-end market cap from split-adjusted closes and the share count in the units it was filed, then divide by those dollar totals. Nothing here is a third-party estimate.